New England Securities’s AbbVie ABBV Stock Holding History

New England Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$798K	Sell	12,198 -2,133	-15%	-$134K	0.28%	91
2014 Q3	$828K	Buy	14,331 +689	+5%	+$38.3K	0.29%	84
2014 Q2	$770K	Buy	13,642 +171	+1%	+$8.97K	0.27%	91
2014 Q1	$692K	Buy	13,471 +249	+2%	+$12.6K	0.27%	94
2013 Q4	$698K	Buy	13,222 +87	+0.7%	+$4.28K	0.29%	86
2013 Q3	$588K	Buy	13,135 +11,350	+636%	+$503K	0.3%	86
2013 Q2	$74K	Buy	+1,785	New	+$78.1K	0.05%	341

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

New England Securities's ABBV Position: Q4 2014 in Review

New England Securities reduced its AbbVie (ABBV) stake by 15% in Q4 2014, selling an estimated $134K and leaving 12,198 shares worth $798K. The position accounts for 0.28% of the portfolio, ranked #91.

New England Securities first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. The position peaked at $828K in Q3 2014. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

New England Securities held 12,198 shares of AbbVie worth $798K as of Q4 2014.
New England Securities sold 2,133 AbbVie shares in Q4 2014, an estimated $134K.
AbbVie made up 0.28% of New England Securities's portfolio in Q4 2014, its #91 holding.
New England Securities first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
New England Securities's AbbVie position peaked at $828K in Q3 2014.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.